医学
肝病
肝移植
肌酐
肾
肾脏疾病
肾移植
移植
阶段(地层学)
内科学
重症监护医学
胃肠病学
泌尿科
古生物学
生物
作者
Gayatri Nair,Vinay Nair
标识
DOI:10.1016/j.cld.2022.01.011
摘要
End-stage kidney disease (ESKD) after liver transplantation is associated with high morbidity and mortality. This increase in mortality can be offset by performing a kidney transplant at the time of the liver transplant in select cases. Accordingly, Margreiter and colleague; s performed the first simultaneous liver-kidney (SLK) transplant in 1983. The number of SLK transplants has increased by more than 300% since then. In 1990%, 1.7% of all liver transplants in the United States were SLK transplants which increased to 9.9% by 2016. This steep increase was likely due to the implementation of the model of end-stage liver disease (MELD) scoring system in 2002, which is heavily weighted by serum creatinine.
科研通智能强力驱动
Strongly Powered by AbleSci AI